Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Apixaban- Pfizer's Multi-Billion Dollar Income Replacement For Lipitor
Seeking Alpha
Saturday, December 10, 2011 - 12:48pm
tags:
Apixaban, Pfizer, anticoagulants
Pharmacyclics Shares Plunged: What You Need to Know
Motley Fool
Saturday, December 10, 2011 - 12:47pm
tags:
Pharmacyclics, JNJ
1 Biotech Soars While Another Crashes
Motley Fool
Saturday, December 10, 2011 - 12:45pm
tags:
Adeona, Cell Therapeutics, SIGA technologies, PharmAthene
Human Genome Upped to Neutral
Yahoo/Zacks
Saturday, December 10, 2011 - 12:42pm
tags:
Human Genome Sciences
Questcor Acthar Drug Getting Bigger Role
Yahoo/Investor's Business Daily
Saturday, December 10, 2011 - 12:42pm
tags:
Questcor Pharmaceuticals, Acthar
Spectrum Stock Tumbles 6% As Cancer Drug Threatened
Investor's Business Daily
Saturday, December 10, 2011 - 12:40pm
tags:
Spectrum, Fusilev, generics
Spectrum’s Fusilev Doesn’t Face Threat From Generics, CEO Shrotriya Says Q
Bloomberg
Saturday, December 10, 2011 - 12:38pm
tags:
Fusilev, Spectrum Pharmaceuticals, generics, colon cancer
Are Allergan's Numbers Better Than They Look?
Motley Fool
Friday, December 9, 2011 - 12:36pm
tags:
Allergan
Cell Therapeutics Shares Decline on Offering News
Forbes
Friday, December 9, 2011 - 12:04pm
tags:
Cell Therapeutics, stock offering
Gilead Reports Non-inferior Data From Phase 3 Study Of Elvitegravir In HIV
NASDAQ.com
Friday, December 9, 2011 - 12:02pm
tags:
HIV, Gilead, elvitegravir
Ex-Pfizer cancer drug shows mixed results in mid-stage studies
Fierce Biotech
Friday, December 9, 2011 - 11:59am
tags:
Pfizer, Puma Biotechnology, breast cancer, neratinib, PB272
Affymax: A Soaring Biotech With Room to Run
Motley Fool
Friday, December 9, 2011 - 11:43am
tags:
Affymax, peginesatide
1-Star Stocks Poised to Plunge: Inhibitex?
Motley Fool
Friday, December 9, 2011 - 11:31am
tags:
Inhibitex
Pfizer Wins Review of Punitive-Damages Award in Prempro Case
Bloomberg
Friday, December 9, 2011 - 11:28am
tags:
Pfizer, Prempro, Wyeth, HRT
Diabetes Meds, Pancreatitis & Prescribing Habits
Pharmalot
Friday, December 9, 2011 - 11:26am
tags:
diabetes, pancreatitis, physicians, Byetta, Amylin, Januvia, Merck
Obama supports less access to morning-after pill
Reuters
Friday, December 9, 2011 - 11:25am
tags:
Obama, Plan B contraceptive, morning-after pill
Five Biotech Stocks to Watch Going into Big Doctors' Meeting
Minyanville
Friday, December 9, 2011 - 11:11am
tags:
Seattle Genetics, ONYX Pharmaceuticals, Incyte, Celgene, Ariad Pharmaceuticals
The Worst Biotech CEO of 2011 Is ...
TheStreet.com
Friday, December 9, 2011 - 10:57am
tags:
biotech, Mitchell Gold, Dendreon
Future Dividend Growth In Bristol-Myers Squibb Will Be Weak
Seeking Alpha
Friday, December 9, 2011 - 9:41am
tags:
dividends, Bristol-Myers Squibb
FDA finds quality lapses, other serious problems in factory for unavailable J&J cancer drug
Yahoo/AP
Friday, December 9, 2011 - 9:40am
tags:
FDA, JNJ, Doxil

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.